Yongfeng Yu, Jianya Zhou, Ying Yuan, Minglei Zhuo, Jianhua Shi, Yueyin Pan, Lin Shen, Siqing Fu, Alex Spira, Lin Wu, Dongqing Lv, Bin Yang, Jing Zheng, Xuefeng Fang, Baorong Song, Shengtang Ma, Jing Li, Boyu Zhong, Tony Zhang, Shun Lu. "A phase 1/2 study of TSN1611, a highly selective oral KRAS G12D inhibitor, in solid tumors: Efficacy and safety in
                    <i>KRAS</i>
                    G12D–mutated NSCLC patients.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.8516